DNAJA3 and NTRK1

  • Number of citations of the paper that reports this interaction (PMID 15753086)
  • 12
  • Data Source:
  • HPRD (in vivo, two hybrid, in vitro)

DNAJA3

NTRK1

Gene Name DnaJ (Hsp40) homolog, subfamily A, member 3 neurotrophic tyrosine kinase, receptor, type 1
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 38 interactors: ALS2CR11 ATXN1 BRCA1 CARM1 COIL FAM131C FAM214B FOSL2 FRMD6 GCC1 GFI1B GRB2 HSPA1A HSPA8 HSPA9 IFNGR2 INPP5J JAK2 KDM1A KRAS MET MYO15B NFKBIA NFKBIB NOC4L NTRK1 OSGIN1 PRMT6 RAD51 RASA1 RELA RNF34 SMAD9 STK16 TCF19 USP7 VHL ZBTB22 36 interactors: ABL1 ARHGAP32 CAV1 CRK DNAJA3 DYNLL1 FRS2 FRS3 GIPC1 GRB2 IRS1 IRS2 KIDINS220 MAPK3 MATK NEDD4 NEDD4L NGF NGFR NTF3 PIK3R1 PLCG1 PTPN1 PTPN11 RAP1A RASA1 RASGRF1 RUSC1 SH2B1 SH2B2 SHC1 SHC2 SHC3 SQSTM1 TRAF6 UBB
Entrez ID 9093 4914
HPRD ID 09758 01869
Ensembl ID ENSG00000103423 ENSG00000198400
Uniprot IDs B3KM81 E7ES32 Q53G26 Q59E88 Q96EY1 P04629
PDB IDs 2CTT 2DN9 1HE7 1SHC 1WWA 1WWW 2IFG 4AOJ 4F0I 4GT5
Enriched GO Terms of Interacting Partners?
Tagcloud ?
acted  adenocarcinoma  allylamino  causing  cochaperone  colony  concluded  conversely  counteracting  counterparts  demethoxy  differently  egfr  enhancing  geldanamycin  hsp70  hsp90  interacted  inversely  isoforms  oncogenic  orthotropic  proteasomal  restored  subcutaneous  tid1  ubiquitinylation  xenograft 
aacr  accelerated  advancements  ago  approved  developments  discov  encodes  fda  fusions  harboring  next  oncd  oncogene  oncogenic  oncology  originally  precision  rationale  rearrangements  revisit  scientific  throughput  tpm3  transforming  trka  trkb  trkc 
Tagcloud (Difference) ?
acted  adenocarcinoma  allylamino  causing  cochaperone  colony  concluded  conversely  counteracting  counterparts  demethoxy  differently  egfr  enhancing  geldanamycin  hsp70  hsp90  interacted  inversely  isoforms  orthotropic  proteasomal  restored  subcutaneous  tid1  ubiquitinylation  xenograft 
aacr  accelerated  advancements  ago  approved  developments  discov  encodes  fda  fusions  harboring  next  oncd  oncogene  oncology  originally  precision  rationale  rearrangements  revisit  scientific  throughput  tpm3  transforming  trka  trkb  trkc 
Tagcloud (Intersection) ?
oncogenic